NCT04577170View on ClinicalTrials.gov

Pulsatility Index, Vasomotor Reactivity and Leukoencephalopathy in Fabry Patients

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

January 20, 2023

Conditions
Fabry Disease
Interventions
DIAGNOSTIC_TEST

Transcranial Doppler (TCD) and Transcranial Color-Coded Duplex (TCCD) ultrasonography

Transcranial Doppler (TCD) and Transcranial Color-Coded Duplex (TCCD) ultrasonography will be performed in consecutive FD patients. All TCD and TCCD studies will be performed by stroke neurologists experienced in vascular sonography.

Trial Locations (1)

12462

"Second Department of Neurology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece", Athens

All Listed Sponsors
lead

National and Kapodistrian University of Athens

OTHER

NCT04577170 - Pulsatility Index, Vasomotor Reactivity and Leukoencephalopathy in Fabry Patients | Biotech Hunter | Biotech Hunter